REGISTRATION OF ORPHAN AND BIOTECHNOLOGICAL PRODUCTS UNDER THE RULES OF EURASIAN ECONOMIC UNITY
Legal acts of Eurasian Economic Unity, which regulate the process of registration of orphan and biotechnological products, are given. Features of the registration and research of biosimilars and orphan drugs, which are reflected in the Eurasian Economic Unity’s legislation, are marked. The most typical mistakes during planning of biosimilars’ research are reflected.